Application of Sanger Sequencing Technology in the Clinical Trials of In Vitro Diagnostic Reagents and Requirements for Performance Evaluation

Xu Chao, Fang Li, Zheng Shengwei, Liu Xuan, Li Xiaoli, He Jingyun

Chinese Pharmaceutical Affairs ›› 2026, Vol. 40 ›› Issue (5) : 524-528.

PDF(937 KB)
PDF(937 KB)
Chinese Pharmaceutical Affairs ›› 2026, Vol. 40 ›› Issue (5) : 524-528. DOI: 10.16153/j.1002-7777.2026-02-0034
Supervision & Administration: Special Column on Quality Control Research of In Vitro Diagnostic Reagents

Application of Sanger Sequencing Technology in the Clinical Trials of In Vitro Diagnostic Reagents and Requirements for Performance Evaluation

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 40(5): 524-528 https://doi.org/10.16153/j.1002-7777.2026-02-0034

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(937 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉